Our specific focus was on FOXA1 due to its elevated expression among diabetes-related genes within the hormone-receptor-positive breast cancer (HR+ BC) subtype, as determined by gene expression analysis of breast cancer patient tissue samples. This evidence concerns the gene NR4A1 and breast cancer.